Ultramutated cancers are typically identified through comprehensive genomic sequencing techniques such as whole-exome sequencing or whole-genome sequencing. These methods allow scientists to quantify the number of mutations present in the DNA of cancer cells. A specific threshold of mutations per megabase of DNA is used to classify a cancer as ultramutated.
